Open AccessAppropriateness of dabigatran dosing in patients with nonvalvular atrial fibrillation (NVAF): A retrospective study conducted in a tertiary care university hospital in the eastern province of Saudi Arabia
Author(s) -
Nasser Alali,
Mahmoud Hassan Mahmoud,
Mousa Alharbi,
Sami Ghazal
Publication year - 2019
Publication title -
journal of the saudi heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 16
eISSN - 2212-5043
pISSN - 1016-7315
DOI - 10.1016/j.jsha.2019.05.002
Subject(s) - medicine , dabigatran , dosing , atrial fibrillation , retrospective cohort study , emergency medicine , stroke (engine) , medical prescription , warfarin , intensive care medicine , pharmacology , mechanical engineering , engineering
This study revealed inappropriate prescription of reduced doses of dabigatran in a large number of patients. Age was identified as the main driving factor for underdosing. Physicians' and pharmacists' awareness regarding this type of high-risk medication should be improved to ensure appropriate and safe use of this commonly used drug.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom